Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.14% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 8.59% |
| 4 | Utilities | 7.75% |
| 5 | Technology | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Idexx Laboratories
IDXX
$43.9B
| $16.2M | 0.04% |
275,596
+215,446
| +358% | +$13.6M |
|
|
INFI
602
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $16.2M | 0.04% |
1,208,980
+737,926
| +157% | +$8.79M |
|
|
LQ
603
DELISTED
La Quinta Holdings Inc.
LQ
| $16.2M | 0.04% |
851,498
-512,891
| -38% | -$9.94M |
|
|
GST
604
DELISTED
Gastar Exploration Inc.
GST
| $16.2M | 0.04% |
2,754,570
-88,611
| -3% | -$651K |
|
|
MON
605
DELISTED
Monsanto Co
MON
| $16.2M | 0.04% |
143,633
+52,974
| +58% | +$6.19M |
|
|
BNY
606
Bank of New York Mellon
BNY
$108B
| $16.1M | 0.04% |
415,499
+306,739
| +282% | +$11.9M |
|
|
MBT
607
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $16M | 0.04% |
1,069,977
+864,199
| +420% | +$15.8M |
|
608
Elevance Health
ELV
$86.9B
| $15.9M | 0.04% |
132,640
+424
| +0.3% | +$48.6K |
|
609
FerroAtlántica
GSM
$762M
| $15.8M | 0.04% |
867,580
+492,610
| +131% | +$9.81M |
|
|
TSRO
610
DELISTED
TESARO, Inc.
TSRO
| $15.8M | 0.04% |
585,332
+377,696
| +182% | +$11.1M |
|
611
Constellium
CSTM
$3.66B
| $15.7M | 0.04% |
639,471
-57,770
| -8% | -$1.67M |
|
|
TIVO
612
DELISTED
Tivo Inc
TIVO
| $15.7M | 0.04% |
795,385
+332,911
| +72% | +$7.51M |
|
|
SLCA
613
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $15.7M | 0.04% |
251,212
-1,865
| -0.7% | -$116K |
|
|
AGN
614
CALL
DELISTED
Allergan plc
AGN
| $15.7M | 0.04% |
65,000
+25,000
| +63% | +$5.59M |
|
615
AMC Entertainment Holdings
AMC
$2.28B
| $15.7M | 0.04% |
68,210
-14,152
| -17% | -$3.34M |
|
|
FCE.A
616
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $15.7M | 0.04% |
800,854
-690,570
| -46% | -$13.8M |
|
617
Rockwell Automation
ROK
$48.5B
| $15.7M | 0.04% |
142,548
-13,532
| -9% | -$1.59M |
|
618
WisdomTree
WT
$3.56B
| $15.7M | 0.04% |
1,375,241
+875,689
| +175% | +$9.96M |
|
619
Whirlpool
WHR
$2.63B
| $15.6M | 0.04% |
107,310
-204,447
| -66% | -$30.2M |
|
|
CEB
620
DELISTED
CEB Inc.
CEB
| $15.6M | 0.04% |
259,853
+9,424
| +4% | +$616K |
|
621
Southwest Airlines
LUV
$19.8B
| $15.5M | 0.04% |
459,405
+172,262
| +60% | +$5.26M |
|
622
PTC Therapeutics
PTCT
$5.83B
| $15.5M | 0.04% |
351,734
-95,147
| -21% | -$2.98M |
|
623
Boston Properties
BXP
$10.8B
| $15.5M | 0.04% |
133,715
+107,326
| +407% | +$12.8M |
|
|
BCR
624
DELISTED
CR Bard Inc.
BCR
| $15.4M | 0.04% |
+108,218
| New | +$16M |
|
625
Howard Hughes
HHH
$3.97B
| $15.4M | 0.04% |
107,917
+104,048
| +2,689% | +$15.2M |
|
Similar funds
Israel Englander's Q3 2014 Portfolio in Review
As of Q3 2014, Israel Englander held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Israel Englander's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Israel Englander added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Israel Englander's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Israel Englander fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Israel Englander opened 1,066 new positions and closed 749 in Q3 2014.
- Israel Englander's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.